Abrdn Healthcare Investors (HQH) Insider Trading Activity

NYSE$20.08+0.02 (0.10%)
Market Cap
$1.08B
Sector
Financial Services
Industry
Asset Management
Rank in Sector
484 of 636
Rank in Industry
79 of 107

HQH Insider Trading Activity

HQH Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Abrdn Healthcare Investors

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Insider Activity of Abrdn Healthcare Investors

Over the last 12 months, insiders at Abrdn Healthcare Investors have bought $0 and sold $0 worth of Abrdn Healthcare Investors stock.

On average, over the past 5 years, insiders at Abrdn Healthcare Investors have bought $93,737 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,000 shares for transaction amount of $18,880 was made by DiMartino Rose (director) on 2024‑07‑16.

List of Insider Buy and Sell Transactions, Abrdn Healthcare Investors

2024-07-16PurchaseDiMartino Rosedirector
1,000
0.0022%
$18.88
$18,880
-2.90%
2024-04-09PurchaseGoetz Kathleendirector
525
0.001%
$16.42
$8,622
+15.73%
2024-01-02PurchaseReit Todddirector
1,000
0.002%
$16.93
$16,929
+9.80%
2023-12-28PurchaseMaher Billdirector
1,000
0.002%
$16.58
$16,580
+12.12%
2023-12-21PurchaseGoodson Alan RVice President
170
0.0003%
$16.13
$2,742
+13.85%
2023-09-25PurchaseOMSTEAD DANIEL RPresident
9,500
0.0176%
$15.63
$148,515
+13.67%
2023-09-20PurchaseOMSTEAD DANIEL RPresident
9,500
0.0179%
$15.88
$150,829
+12.60%
2022-03-23PurchaseGoetz Kathleen
73.53
0.0002%
$20.42
$1,501
-2.46%
2022-01-26PurchaseGoetz Kathleendirector
481
0.0012%
$21.52
$10,349
-4.39%
2020-10-26PurchaseOMSTEAD DANIEL RPresident
5,200
0.0127%
$20.53
$106,744
+25.99%
2020-10-21PurchaseOMSTEAD DANIEL RPresident
5,050
0.0124%
$20.68
$104,427
+26.32%
2020-09-23PurchaseBailey Jeffrey Allendirector
490
0.0012%
$20.39
$9,991
+26.68%
2020-05-21PurchaseOMSTEAD DANIEL RPresident
5,000
0.0125%
$21.01
$105,054
+8.17%
2020-03-17PurchaseOMSTEAD DANIEL RPresident
6,800
0.0131%
$16.24
$110,412
+35.31%
2018-12-26PurchaseOMSTEAD DANIEL RPresident
6,300
0.0128%
$17.14
$107,971
+16.83%
2018-10-25PurchaseOMSTEAD DANIEL RPresident
5,500
0.0133%
$20.43
$112,344
+2.45%
2018-10-17PurchaseOMSTEAD DANIEL RPresident
3,882
0.01%
$21.78
$84,534
-4.65%
2018-01-25PurchaseKent Thomas Mdirector
1,100
0.0032%
$24.19
$26,605
-7.24%
2016-01-06PurchaseGasperoni Timothy L
862
0.003%
$28.98
$24,978
-12.42%
2015-06-29PurchaseSTEBBINS LUCINDA Hdirector
2,000
0.0085%
$35.74
$71,480
-14.23%
Total: 38

Insider Historical Profitability

9.75%
OMSTEAD DANIEL RPresident
178269
0.331%
$3.58M190
+13.58%
STEBBINS LUCINDA Hdirector
6513
0.0121%
$130,652.4040
+0.99%
LEWIN LAWRENCE Sdirector
4359
0.0081%
$87,434.3210
+7.38%
MACK ROBERT Pdirector
3910
0.0073%
$78,429.1210
+6.59%
Kent Thomas Mdirector
1100
0.002%
$22,066.0010
<0.0001%
Goetz Kathleendirector
1080
0.002%
$21,655.3530
+2.96%
Maher Billdirector
1000
0.0019%
$20,060.0010
+12.12%
Reit Todddirector
1000
0.0019%
$20,060.0010
+9.8%
DiMartino Rosedirector
1000
0.0019%
$20,060.0010
<0.0001%
Gasperoni Timothy L
862
0.0016%
$17,291.7210
<0.0001%
REARDON WILLIAM Sdirector
646
0.0012%
$12,958.7610
+15.38%
BONNEY MICHAEL Wdirector
650
0.0012%
$13,039.0010
+15.38%
Bailey Jeffrey Allendirector
490
0.0009%
$9,829.4010
+26.68%
POHOTSKY OLEG Mdirector
200
0.0004%
$4,012.0010
+15.22%
Goodson Alan RVice President
170
0.0003%
$3,410.2010
+13.85%

Historical Insider Profitability vs. Competitors

$445,498,142
424
4.91%
$1.45B
$24,261,353
256
5.00%
$1.43B
$97,214,463
255
7.59%
$841.75M
$66,393,680
192
4.06%
$831.14M
$11,761,237
147
7.75%
$1.38B
$4,088,463
108
9.80%
$1.49B
$23,710,801
106
19.24%
$1.26B
$15,297,842
99
18.06%
$1.05B
$7,810,871
84
12.70%
$845.34M
$5,754,884
73
9.77%
$1.79B
$5,209,681
62
4.88%
$1.74B
$8,693,284
60
11.27%
$1.16B
$3,606,814
57
-2.60%
$873.13M
$4,275,088
52
10.89%
$856.61M
$5,618,085
42
27.30%
$1.16B
Tekla Healthcare Investors
(HQH)
$1,771,470
38
9.75%
$1.08B
$99,073,251
29
0.24%
$893.4M
$2,632,350
17
22.12%
$934.27M
$929,027
5
9.89%
$1.03B

HQH Institutional Investors: Active Positions

Increased Positions58+45.67%1M+11.57%
Decreased Positions47-37.01%612,483-5.01%
New Positions18New291,860New
Sold Out Positions15Sold Out296,507Sold Out
Total Postitions138+8.66%13M+6.55%

HQH Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Morgan Stanley$79,290.007.78%4.2M+415,526+10.97%2025-09-30
Penserra Capital Management Llc$22,622.002.22%1.2M+159,618+15.36%2025-09-30
Raymond James Financial Inc$22,378.002.2%1.19M-113,714-8.75%2025-09-30
Royal Bank Of Canada$9,406.000.92%498,478-6,807-1.35%2025-09-30
Ameriprise Financial Inc$7,773.000.76%411,938+64,868+18.69%2025-09-30
Lpl Financial Llc$7,650.000.75%405,400+12,333+3.14%2025-09-30
Advisors Asset Management, Inc.$6,850.000.67%363,020+11,661+3.32%2025-09-30
Needham Investment Management Llc$5,509.000.54%291,930+8,752+3.09%2025-09-30
Wny Asset Management, Llc$4,037.000.4%213,950+14,024+7.01%2025-09-30
Bank Of America Corp /De/$3,605.000.35%191,036+339+0.18%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.